Calyxt Reports Fourth Quarter 2022 Financial Results and Provides Corporate Update

/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced operating and financial results for its fourth quarter...

Related Keywords

Minnesota ,United States ,California ,Roseville ,San Diego ,Rory Riggs ,Michaela Carr ,Prnewswire Calyxt Inc ,Calyxt Inc ,Current Customer Projects Under Development ,Nasdaq ,Exchange Commission ,Payroll Protection Program ,Cibus Global ,Cibus Inc ,Evologic Technologies ,Plant Cell Matrix ,Chief Executive Officer ,Nasdaq Capital Market ,Chief Executive ,Registration Statement ,Customer Projects Under Development ,Global Infrastructure Partner ,Enable Growth ,Proprietary Plant Cell Matrix ,Evologic Technologies Gmbh ,Three Months Ended December ,Merger Agreement ,Securities Litigation Reform Act ,Annual Report ,Ridge Road ,Except Par Value ,Share Amounts ,Thousands Except Shares ,Per Share Amounts ,Calyxt ,Nc ,